Live Breaking News & Updates on Johnc Martin Foundation
Stay updated with breaking news from Johnc martin foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
One bright spot: More than 80 countries are achieving targets for vaccinating children against HBV, including all countries in North and South America except Venezuela. ....
In memoriam May 3, 2021 Dr John C Martin, former chairman and CEO of Gilead Sciences, Inc, passed away on March 30 in California at the age of 70. A true innovator, John transformed Gilead from a mid-sized player into a juggernaut in the virology space, pioneering a series of revolutionary single-pill treatments that effectively reduced HIV from a deadly pandemic to a disease that is now both preventable and controllable with highly effective antiretroviral medicines. Under his stewardship, Gilead created highly effective treatments for hepatitis B and revolutionized the treatment of the hepatitis C virus (HCV) with the launch of Sovaldi, the first oral treatment for HCV in 2013. This was followed by a series of even more effective treatments, which have reduced treatment duration to 12 weeks and cure rates to above 95 percent. ....
John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C. John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit.Paul Sakuma/Associated Press April 27, 2021, 6:43 p.m. ET John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures hepatitis C, died on March 30 in Palo Alto, Calif. He was 69. ....
A Statement from the Leadership of the University of Maryland School of Medicineâs Institute of Human Virology on the Passing of Dr. John Martin Dr. Martin Received IHVâs 2014 Lifetime Achievement Award for Public Service and Was IHVâs 2017 Annual Marlene and Stewart Greenebaum Lecturer John Martin, PhD. Dr. Martin was a leader in supporting access to life-saving anti-HIV medications that although still under patent were made widely and affordably available to millions around the world infected with HIV, and for prevention through pre-exposure drug therapy. He was a tremendous clinical scientist, businessman, global public health leader, philanthropist, and good friend. ....
A Statement From the Leadership of the Global Virus Network on the Passing of Dr. John Martin newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.